 SAN FRANCISCO, Jan. 19, 2023 GLOBE NEWSWIRE Hagens Berman urges Y-mAbs Therapeutics, Inc. NASDAQ: YMAB investors who suffered significant losses to submit your losses now. Class Period: Oct. 6, 2020 Oct. 28, 2022Lead Plaintiff Deadline: Mar. 20, 2023Visit: Contact An Attorney Now: ... The post HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Y-mAbs Therapeutics YMAB Investors with Significant Losses to Contact... 